US Stock MarketDetailed Quotes
ELAB Elevai Labs
- 0.504
- -0.021-3.94%
Close Jul 12 16:00 ET
- 0.512
- +0.008+1.57%
Post 19:58 ET
9.53MMarket Cap-1896P/E (TTM)
0.549High0.480Low162.59KVolume0.549Open0.525Pre Close83.59KTurnover2.43%Turnover RatioLossP/E (Static)18.89MShares4.24452wk High3.82P/B3.38MFloat Cap0.48052wk Low--Dividend TTM6.70MShs Float4.244Historical High--Div YieldTTM13.18%Amplitude0.480Historical Low0.514Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Elevai Labs Stock Forum
Elevai Biosciences, a division of Elevai Labs, Inc. (NASDAQ: ELAB), is making waves in the medical community with its groundbreaking preclinical findings on EL-22, a promising therapeutic for obesity treatment. The company's focus on combining cutting-edge aesthetic medicine development...
NEWS
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
EL-22 demonstrated physiological, physical, and functional improvements in mdx mice, a model of Duchenne muscular dystrophy.
The preclinical data showed a significant increase in anti-myostatin IgG antibody concentration and a decrease in creatine kinase levels.
Administering EL-22 to mdx mice resulted in improved physical activity and motor funct...
NEWS
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
NEWS
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
No comment yet